GAVI: GK, General Studies and Current Affairs

COVID-19 Vaccine: Serum Institute of India to produce additional 100 million doses for India

The Serum Institute of India recently announced that it will produce additional 100 million COVID-19 vaccines for low- and middle- income countries by 2021. Highlights Earlier, the institute had committed to deliver 100 million vaccines. Now a total of 200 million doses of COVID-19 vaccines are to be delivered to India by 2021. The Institute ..

EU enters into deal with AstraZeneca, for first Covid-19 vaccine

The European Union has entered into an agreement to but at least 300 million doses of AstraZeneca’s potential COVID 19 vaccine in the first-ever such deal in advance by the group. This is expected to weaken the global approach taken by the World Health Organization in this regard. What is the Deal? The European Union, ..

Russia to Launch First COVID 19 Vaccine

Russia has announced that it is going to launch the first-ever vaccine for the deadly COVID 19 disease as early as in a week. The vaccine has been developed by Gamaleya Research Institute and the Defence Ministry of the country. The vaccine is set to be registered by August 12. Details of the Vaccine The ..

India approves second Vaccine Trial

The Drug Controller General of India approved to begin vaccine trial of Zydus Cadila. The firm is to conduct the vaccine trials in two phases. This is the second vaccine trial approved by India after Bharat Biotech’s COVAXIN. Highlights The DCGI approved the vaccine trials after the animal trials of the vaccine was satisfactory. The ..

India pledges $15 million to International vaccine alliance GAVI

On June 4, India made an announcement in the virtual Global Vaccine Summit to pledge $15 million to the international vaccine alliance GAVI. At the same time, India is also eligible for support from GAVI. India’s financial support will amount in lowering down the vaccine prices globally. This donation comes in the context of India ..